首頁 > 市場調查報告書 > 製藥

處方藥疼痛

市場調查報告書

商品編碼

1789412

局部鎮痛藥市場：按藥物類別、劑型、治療用途、疼痛類型、分佈、藥物類型、藥物配方、性別、年齡層、分銷管道和地區分類

Topical Analgesic Market, By Drug Class, By Formulation, By Therapeutic Application, By Pain Type, By Distribution, By Drug Type, By Drug Composition, By Gender, By Age Group, By Distribution Channel, By Geography

出版日期: 2025年07月15日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

局部止痛藥市場規模預計在 2025 年達到 121 億美元，預計到 2032 年將達到 185.6 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	121億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	6.30%	2032年預測	185.6億美元

全球局部止痛藥市場是疼痛管理製藥行業的一個重要組成部分，涵蓋了各種用於局部緩解各種疼痛狀況的局部治療產品。局部止痛藥包括乳膏、凝膠、貼片、噴霧和軟膏，它們透過經皮吸收將活性藥物成分直接輸送到患處，在提供靶向疼痛緩解的同時，最大限度地減少全身暴露和相關副作用。該市場涉及多種治療用途，用於治療急性和慢性疼痛狀況，包括關節炎、肌肉拉傷、下背痛、神經病變疼痛和運動相關損傷。肌肉骨骼疾病的盛行率不斷上升、人口老化以及消費者對非侵入性疼痛管理替代方案的日益成長的偏好，這些都對市場擴張做出了重大貢獻。推動市場成長的關鍵活性成分包括薄荷醇、辣椒素、水楊酸鹽、非類固醇消炎劑和Lidocaine，每種成分都有不同的鎮痛作用機制。市場提供處方藥和非處方藥，以滿足多樣化的消費者需求和醫療保健提供者的偏好。經皮貼片和奈米製劑等藥物傳遞系統的技術進步正在提高產品功效和患者依從性，進一步刺激市場發展，並為創新治療解決方案創造機會。

市場動態

全球局部止痛藥市場主要受若干相互關聯的因素驅動，這些因素支撐著市場的持續成長和擴張。全球人口老化以及關節炎、纖維肌痛和神經病變疼痛等慢性疼痛疾病的盛行率不斷上升，導致對有效的局部疼痛管理解決方案的需求龐大。人們日益意識到口服止痛藥的副作用，包括胃腸道併發症和依賴性風險，這促使消費者和醫療保健提供偏好轉向能夠減少全身暴露並提供局部緩解的局部用藥。體育和健身文化的擴展以及隨之而來的體育活動參與度的提高，導致對用於治療運動相關損傷和肌肉疲勞的局部止痛藥的需求持續成長。然而，市場面臨著可能阻礙其成長軌跡的重大限制。對新產品核可（尤其是處方箋藥）核准的嚴格監管要求，設定了市場進入門檻，並增加了製藥公司的開發成本。局部製劑有限的滲透深度限制了其對深部疼痛的有效性，從而可能限制市場覆蓋範圍和消費者的接受度。消費者對價格的高度敏感，尤其是在新興市場，為高價位的創新產品帶來了挑戰。然而，市場格局也蘊藏著巨大的機會。先進藥物傳輸技術（例如基於奈米技術的製劑和滲透增強系統）的發展，為提升療效和拓展應用領域提供了機會。對天然和有機止痛藥日益成長的需求，為植物來源製劑和潔淨標示替代品創造了一個利基市場。亞太和拉丁美洲的新興市場由於醫療保健支出的增加、疼痛管理意識的增強以及購買力強勁的中產階級人口的不斷壯大，展現出巨大的成長潛力。

本次調查的主要特點

本報告對全球局部鎮痛藥市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球局部止痛藥市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員將透過用於分析全球局部止痛藥市場的各種策略矩陣更輕鬆地做出決策。

下背部疼痛
肌肉疼痛
頸部疼痛
骨關節炎
偏頭痛
頭痛和叢集性頭痛
足底筋膜炎
坐骨神經痛
黏液囊炎
慢性肌筋膜疼痛
肋軟骨炎
急性味覺障礙
神經線病變
椎間滑脫
顳顎關節障礙症
肌腱炎
牙痛
糖尿病周邊神經病變
類風濕性關節炎
發炎性疾病
其他（術後疼痛等）

7. 2020 年至 2032 年全球局部止痛藥市場（依疼痛類型）

急性
慢性的

8. 全球局部止痛藥市場分佈，2020-2032

非處方藥
處方箋

9. 2020 年至 2032 年全球局部止痛藥市場（以藥物類型）

原廠產品
非專利的

10. 2020-2032 年全球局部止痛藥市場（以藥物劑型）

單一代理
組合藥物

11. 2020-2032 年全球局部止痛藥市場（依性別）

男性
女士

12. 2020 年至 2032 年按年齡分類的全球局部止痛藥市場

成人
孩子們
老年人

13. 全球局部止痛藥市場依通路分類，2020-2032 年

醫院藥房
零售藥局
網路藥局

14. 2020 年至 2032 年全球局部止痛藥市場（按地區）

北美洲
拉丁美洲
歐洲
亞太地區
中東
非洲

第15章競爭格局

Johnson & Johnson
GlaxoSmithKline plc（Haleon）
Sanofi
Reckitt Benckiser Group plc
Hisamitsu Pharmaceutical Co., Inc.
Perrigo Company plc
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Boehringer Ingelheim International GmbH
Endo International plc
Topical BioMedics, Inc.
The Mentholatum Company
Pernix Therapeutics
Hikma Pharmaceuticals PLC

第 16 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第17章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8245

Topical Analgesic Market is estimated to be valued at USD 12.10 Bn in 2025 and is expected to reach USD 18.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 12.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.30%	2032 Value Projection:	USD 18.56 Bn

The global topical analgesic market represents a critical segment within the broader pain management pharmaceutical industry, encompassing a diverse range of externally applied therapeutic products designed to provide localized relief from various pain conditions. Topical analgesics, including creams, gels, patches, sprays, and ointments, deliver active pharmaceutical ingredients directly to affected areas through transdermal absorption, offering targeted pain relief while minimizing systemic exposure and associated side effects. This market serves multiple therapeutic applications, addressing acute and chronic pain conditions such as arthritis, muscle strains, back pain, neuropathic pain, and sports-related injuries. The increasing prevalence of musculoskeletal disorders, aging demographics, and growing consumer preference for non-invasive pain management alternatives have significantly contributed to market expansion. Key active ingredients driving market growth include menthol, capsaicin, salicylates, NSAIDs, and lidocaine, each offering distinct mechanisms of action for pain relief. The market encompasses both prescription and over-the-counter formulations, catering to diverse consumer needs and healthcare provider preferences. Technological advancements in drug delivery systems, including transdermal patches and nano-formulations, have enhanced product efficacy and patient compliance, further stimulating market development and creating opportunities for innovative therapeutic solutions.

Market Dynamics

The global topical analgesic market is primarily driven by several interconnected factors that collectively fuel sustained growth and market expansion. The increasing geriatric population worldwide, coupled with rising prevalence of chronic pain conditions such as arthritis, fibromyalgia, and neuropathic pain, creates substantial demand for effective topical pain management solutions. Growing awareness about the adverse effects of oral analgesics, including gastrointestinal complications and dependency risks, has shifted consumer and healthcare provider preferences toward topical alternatives that offer localized relief with reduced systemic exposure. The expanding sports and fitness culture, accompanied by increased participation in physical activities, generates consistent demand for topical analgesics addressing sports-related injuries and muscle fatigue. However, the market faces significant restraints that could impede growth trajectory. Stringent regulatory requirements for new product approvals, particularly for prescription formulations, create barriers to market entry and increase development costs for pharmaceutical companies. Limited penetration depth of topical formulations restricts their effectiveness for deep-seated pain conditions, potentially limiting market scope and consumer adoption. Price sensitivity among consumers, especially in emerging markets, poses challenges for premium-priced innovative products. Nevertheless, substantial opportunities exist within the market landscape. The development of advanced drug delivery technologies, including nanotechnology-based formulations and enhanced permeation systems, presents opportunities for improved therapeutic efficacy and expanded applications. Growing demand for natural and organic pain relief products creates niches for botanical-based formulations and clean-label alternatives. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to increasing healthcare spending, rising awareness about pain management, and expanding middle-class populations with greater purchasing power.

Key Features of the Study

This report provides an in-depth analysis of the global topical analgesic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global topical analgesic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Sanofi, Reckitt Benckiser, Teva Pharmaceutical Industries, Mylan N.V., Hisamitsu Pharmaceutical, and The Mentholatum Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global topical analgesic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical analgesic market.

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Non-Opioid Topical Analgesics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Diclofenac
- Ibuprofen
- Ketoprofen
- Piroxicam
- Capsaicin-Based Analgesics
- Methyl Salicylate (Salicylates)
- Lidocaine and Local Anesthetics
- CGRP Inhibitors
- Other Non-Opioid Agents
- Opioid-Based Topical Analgesics
Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Creams
- Gels
- Sprays
- Patches
- Ointments & Balms
- Others (Roll-Ons)
Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Back Pain
- Muscle Pain
- Neck Pain
- Osteoarthritis
- Migraine
- Headache and Cluster Headaches
- Plantar Fasciitis
- Sciatica
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Gout, Acute
- Radiculopathy
- Spondylolisthesis
- Temporomandibular Joint Disorder
- Tendonitis
- Toothache
- Diabetic Peripheral Neuropathy
- Rheumatoid Arthritis
- Inflammatory Conditions
- Others (Postoperative Pain, etc.)
Pain Type Insights (Revenue, USD Bn, 2020 - 2032)
- Acute
- Chronic
Distribution Insights (Revenue, USD Bn, 2020 - 2032)
- Over-the-Counter (OTC)
- Prescription-Based
Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
- Brand
- Generic
Drug Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Single
- Combination
Male Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals Pharmacy
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Johnson & Johnson
- GlaxoSmithKline plc (Haleon)
- Sanofi
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Perrigo Company plc
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Boehringer Ingelheim International GmbH
- Endo International plc
- Topical BioMedics, Inc.
- The Mentholatum Company
- Pernix Therapeutics
- Hikma Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Topical Analgesic Market, By Drug Class
- Global Topical Analgesic Market, By Formulation
- Global Topical Analgesic Market, By Therapeutic Application
- Global Topical Analgesic Market, By Pain Type
- Global Topical Analgesic Market, By Distribution
- Global Topical Analgesic Market, By Drug Type
- Global Topical Analgesic Market, By Drug Composition
- Global Topical Analgesic Market, By Gender
- Global Topical Analgesic Market, By Age Group
- Global Topical Analgesic Market, By Distribution Channel
- Global Topical Analgesic Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Topical Analgesic Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Non-Opioid Topical Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    - Diclofenac
    - Ibuprofen
    - Ketoprofen
    - Piroxicam
  - Capsaicin-Based Analgesics
  - Methyl Salicylate (Salicylates)
  - Lidocaine and Local Anesthetics
  - CGRP Inhibitors
  - Other Non-Opioid Agents
Opioid-Based Topical Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Analgesic Market, By Formulation, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ointments & Balms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Roll-Ons)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Analgesic Market, By Therapeutic Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Back Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Muscle Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neck Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Headache and Cluster Headaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Plantar Fasciitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sciatica
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bursitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Myofascial Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Costochondritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gout, Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Radiculopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Spondylolisthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Temporomandibular Joint Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tendonitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toothache
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inflammatory Conditions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Postoperative Pain, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Analgesic Market, By Pain Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Analgesic Market, By Distribution, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Over-the-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prescription-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Analgesic Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Brand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Analgesic Market, By Drug Composition, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Single
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Topical Analgesic Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Topical Analgesic Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Topical Analgesic Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

14. Global Topical Analgesic Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

15. Competitive Landscape

Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc (Haleon)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hisamitsu Pharmaceutical Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Perrigo Company plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Topical BioMedics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
The Mentholatum Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pernix Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies